Published by Iain Gilbert on 17th February 2026
(Sharecast News) - Drugmaker GSK said on Tuesday that the European Commission has approved its asthma and nasal polyps treatment Exdensur (depemokimab) for two separate indications.
URL: http://www.digitallook.com/dl/news/story/35703472/...